Ocular Therapeutix Inc.
OCUL
|
|
|
|
Trading Volume | 19,538 |
|
10.93 - 2.08 |
Market Cap Full | $ 679.8M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 2.6% | 103.8% | 87.5% | -29% |
Q2 | - | -22.2% | -2.1% | -18.8% |
Q3 | - | 1% | -39.2% | 3.2% |
Q4 | - | -22% | 51.2% | -32.3% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2.6 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
9 | 107 | -9.6 | -42.6 | 9 | 18.9 | 25.3 | 1 | - | - | - | -17.4 |
2023 | |||||||||||
39.2 | 54.5 | -12.8 | 17.7 | 3.2 | -19.4 | -12 | -16.7 | -16.9 | -9.2 | -13 | 79.8 |
2022 | |||||||||||
-20.4 | 0.5 | -11.3 | -27.9 | -12.3 | 28.4 | 10.2 | 14.7 | -18.3 | -13 | -17.7 | -5.4 |
2021 | |||||||||||
-12.3 | 1.1 | -10.6 | 12 | -20.8 | -2.6 | -21.3 | -5.4 | -4.7 | -32.7 | 1 | 1.9 |
2020 | |||||||||||
11.7 | 2.5 | 9.8 | 16.4 | 22.2 | 18.3 | -5.9 | 9.8 | -11.6 | 24.8 | 85.2 | 17.7 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.4 | -0.2 | -0.2 | -0.4 |
Q2 | -0.3 | -0.3 | -0.3 | -0.6 |
Q3 | -0.3 | -0.3 | -0.2 | -0.2 |
Q4 | 0 | -0.2 | -0.3 | -1.3 |
A | -0.9 | -1 | -1 | -2.6 |